PHARMA INFLUENCERS | NEWSLETTERS | WEBINARS

Thursday, November 14, 2019

FINANCIAL NEWS


Newsletter

FINANCIAL NEWS from The Pharmaceutical Marketing Group is a regular email newsletter, sharing appointments on the pharmaceutical industry

Direct to your inbox

Stay up to date with the latest appointments by subscribing to LOOK WHO IS ON THE MOVE! from The Pharmaceutical Marketing Group

View the newsletter archive

PPD Announces Confidential Submission of Draft Registration Statement for Proposed Initial Public Offering

WILMINGTON, N.C.--(BUSINESS WIRE)--Pharmaceutical Product Development, LLC today announced that...

Takara Bio Announces Launch of Human iPSC-derived Intestinal Epithelial Cells for Drug Discovery Research

MOUNTAIN VIEW, Calif.--(BUSINESS WIRE)--Takara Bio USA, Inc. (TBUSA) announced...

Myomo Reports Third Quarter 2019 Results

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Myomo, Inc. (NYSE American: MYO) (“Myomo” or...

Tetraphase Pharmaceuticals Reports Third Quarter 2019 Financial Results and Highlights Recent Corporate Developments

WATERTOWN, Mass.--(BUSINESS WIRE)--Tetraphase Pharmaceuticals, Inc. (NASDAQ:TTPH) a biopharmaceutical company...

Omeros Corporation Reports Third Quarter 2019 Financial Results

SEATTLE--(BUSINESS WIRE)--Omeros Corporation (Nasdaq: OMER), a commercial-stage biopharmaceutical company...

Halo Labs Announces Earnings Release and Conference Call Date for Third Quarter 2019

TORONTO--(BUSINESS WIRE)--Halo Labs Inc. ("Halo" or the "Company") (NEO:...

Synlogic Provides Program and Business Update and Reports Third Quarter 2019 Financial Results

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Synlogic, Inc. (Nasdaq: SYBX), a clinical stage...

Cortexyme Announces Third Quarter 2019 Financial Results and Provides Business Update

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Cortexyme, Inc. (Nasdaq: CRTX), a...

Lineage Cell Therapeutics Reports Third Quarter 2019 Financial Results and Provides Business Update

CARLSBAD, Calif.--(BUSINESS WIRE)--Lineage Cell Therapeutics, Inc. (NYSE American and...

Gossamer Bio Announces Third Quarter 2019 Financial Results

SAN DIEGO--(BUSINESS WIRE)--Gossamer Bio, Inc. (Nasdaq: GOSS), a clinical-stage...

PolarityTE Reports Third Calendar Quarter 2019 Results

SALT LAKE CITY--(BUSINESS WIRE)--PolarityTE, Inc. (Nasdaq: PTE), a biotechnology...

Akebia Secures $100 Million Non-Dilutive Term Loan Financing; Reports Third Quarter 2019 Financial Results

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Akebia Therapeutics, Inc. (Nasdaq: AKBA), a biopharmaceutical...